Quote For Glenmark Pharmaceuticals Limited GLEN.BO
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
As of
10:29am GMT
250.10INR
Rs250.10
10:29am GMT
-1.28%
Rs253.35
Rs255.00
263,781
Rs255.90
Rs244.00
Rs346.00
Rs119.15
1.09
228,398
News
Press Releases
No news stories for this company within the last 30 days.
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Saldanha, Gracias |
Non-Executive Chairman of the Board |
25,881,960 |
| Saldanha, Glenn |
Chief Executive Officer, Managing Director, Executive Director |
34,092,800 |
| Desai, Rajesh |
Chief Financial Officer |
9,190,513 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
Rs68,298.36 |
| Shares Outstanding (Mil.) |
269.58 |
| Float (Mil.) |
139.10 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend (Rs INR) |
0.40 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
-- |
| Current Ratio |
-- |
| LT Debt/Equity |
-- |
| Total Debt/Equity |
-- |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
70.77 |
| Price/Sales(TTM) |
2.90 |
| Price/Book(TTM) |
-- |
| Price/Cash Flow(TTM) |
30.89 |
| |
|
| Per Share Data |
| Earnings(TTM) |
Rs3.69 |
| Sales(TTM) |
Rs92.37 |
| Book Value(MRQ) |
Rs-- |
| Cash Flow(TTM) |
Rs8.66 |
| Cash(MRQ) |
Rs-- |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-- |
| Return on Assets(TTM) |
-- |
| Return on Investment(TTM) |
-- |
| |
|
| Margins |
| Gross Margin(TTM) % |
66.50 |
| Operating Margin(TTM) % |
5.82 |
| Profit Margin(TTM) % |
4.03 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives